Primmune Therapeutics, Inc.

Carlsbad, CA

UEI
RCE3KW671H83
CAGE
8J8L4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1929 E Pointe Ave, Carlsbad, CA 92008, USA
Website
primmunerx.com
Founded
2017
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Primmune Therapeutics, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Oral broad spectrum antiviral TLR7 agonist for treatment of lassa fever Contract · HDTRA124C0014 Defense Threat Reduction Agency $11,290,689

Quick answers

What is Primmune Therapeutics, Inc.'s UEI?

Primmune Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is RCE3KW671H83.

What is Primmune Therapeutics, Inc.'s CAGE code?

Primmune Therapeutics, Inc.'s CAGE code is 8J8L4.

What is Primmune Therapeutics, Inc.'s primary NAICS code?

Primmune Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Primmune Therapeutics, Inc. located?

Primmune Therapeutics, Inc.'s physical address in SAM.gov is 1929 E Pointe Ave, Carlsbad, CA 92008, USA.

Is Primmune Therapeutics, Inc. registered in SAM.gov?

Yes. Primmune Therapeutics, Inc.'s SAM.gov registration is active through June 15, 2027.

What is Primmune Therapeutics, Inc.'s most recent federal award?

Primmune Therapeutics, Inc.'s most recent federal contract award is Oral broad spectrum antiviral TLR7 agonist for treatment of lassa fever (HDTRA124C0014), from Defense Threat Reduction Agency, on January 30, 2024.

On GovTribe

See Primmune Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors